Prab: CSV import

2025-02-23T20:56:08Z

CSV import

← Older revision		Revision as of 20:56, 23 February 2025
Line 38:		Line 38:
	[[Category:Drugs]]		[[Category:Drugs]]
	[[Category:Biochemistry]]		[[Category:Biochemistry]]
			== Receptor_antagonist ==
			<gallery>
			File:Antagonist_2.png\|Antagonist 2
			File:Ligand_response_reversible_competitive_antagonist.svg\|Ligand response reversible competitive antagonist
			File:Ligand_response_irreversible_antagonist_and_noncompetitive.svg\|Ligand response irreversible antagonist and noncompetitive
			File:Noncompetitive_a-adrenergic_agonistic_action_of_Phenoxybenzamine.png\|Noncompetitive α-adrenergic agonistic action of Phenoxybenzamine
			File:Ligand_response_comparison.svg\|Ligand response comparison
			</gallery>

Prab at 02:30, 7 September 2023

2023-09-07T02:30:43Z

New page

'''Receptor antagonists''' are specific types of molecules that impede or reduce cellular activity by obstructing receptor sites essential for normal cell function. Commonly referred to as "blockers", they play a crucial role in various therapeutic interventions and physiological processes. Their primary mode of action is to counteract or diminish the effects of agonists, molecules that initiate cellular responses.

== Overview ==
A receptor antagonist can be envisioned as a "key" that fits into a "lock" (the receptor) but does not turn it. By occupying the receptor site, the antagonist prevents other molecules, especially agonists, from binding to the receptor and initiating a response.

== Mechanism of Action ==
Receptor antagonists exert their effects primarily by obstructing active sites on cellular receptors. By doing so, they:

* Counter the effects of [[agonists]]: Agonists are compounds that bind to receptors and activate them, producing a cellular response. Antagonists impede this activation by occupying the receptor site.
* Reduce cellular activity: By preventing the binding of activating molecules to receptors, antagonists slow down or inhibit certain cellular reactions.

== Types ==
Antagonists can be classified based on their interaction with receptors:

* '''Competitive antagonists''': These antagonists compete with agonists for the same receptor binding site. The presence of a competitive antagonist reduces the potency of the agonist.
* '''Non-competitive antagonists''': They bind to a site other than the active site of the receptor. Their binding leads to a change in the receptor's shape, rendering the active site inaccessible to the agonist.

== Examples ==
One of the most renowned types of receptor antagonists is '''beta-blockers'''. Used primarily in the treatment of cardiovascular diseases, beta-blockers inhibit the effects of adrenaline and noradrenaline by binding to their receptors, thus reducing heart rate and blood pressure.

== Clinical Significance ==
Receptor antagonists have found broad applications in medical therapeutics:

* Treatment of [[hypertension]]: By blocking specific receptors, certain drugs can help lower blood pressure.
* Allergy relief: [[Antihistamines]] are a type of receptor antagonist that blocks the action of histamine, providing relief from allergic symptoms.
* Gastrointestinal disorders: [[H2 receptor antagonists]] reduce the production of stomach acid and are used in treating conditions like gastroesophageal reflux disease (GERD).

== See Also ==
* [[Agonist]]
* [[Enzyme inhibitor]]
* [[Signal transduction]]
* [[Pharmacodynamics]]
[[Category:Pharmacology]]
[[Category:Cell biology]]
[[Category:Biochemistry]]
{{-}}
{{chem-stub}}
[[Category:Drugs]]
[[Category:Biochemistry]]

Receptor antagonist - Revision history

Prab: CSV import

Prab at 02:30, 7 September 2023